Ruxolitinib pacritinib fedratinib or momelotinib for thrombocytopenic patients with myelofibrosis

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=HDf15IlNYlA

Claire Harrison, MD, DM, FRCP, FRCPath, Guy's and St Thomas' NHS Foundation Trust, London, UK, comments on the use of different JAK inhibitors including ruxo...

Speaker: Claire Harrison, Institution: Guy's and St Thomas' NHS Foundation Trust, Event: EHA 2022, Format: Interview, Subject: Myeloproliferative Neoplasms, Subject: Myelofibrosis, Field: Treatment, Field: Diagnosis, Field: Trial Updates, Medicines: Ruxolitinib, Medicines: Pacritinib, Medicines: Fedratinib, thrombocytopenia, platelet
#############################